October 26, 2009

Metabolix in tobacco and hospital

No, this is not about Metabolix developing genetically modified tobacco so people can smoke it without having lung cancer.

Metabolix had two announcements last week, the first one is the use of its bioplastic resin Mirel in disposable hospital products; and the other is that Mirel has completed a field trial of genetically engineered tobacco that can potentially be a feedstock source for the company's polyhydroxyalkanoate (PHA) biobased polymers.

More on this post...
Post a Comment